Table 3.
Results for budget impact analysis (price level 2017, in mln euros).
| Perspective | scenario | Costing | Number of individuals (year 1) | Year 2 and further | Baseline BIA (year 1) | Year 2 and further | Lower year 2 and further | Upper year 2 and further |
|---|---|---|---|---|---|---|---|---|
| Societal | maximum implementation | Trial costs | 74100 | 16200 | € 101 | € 22 | –€ 140, | € 190 |
| Societal | conservative trial based | Trial costs | 9386 | 2052 | € 13 | € 3 | –€ 18 | € 24 |
| Societal | Optimistic trial based | Trial costs | 56316 | 12312 | € 77 | € 17 | –€ 107 | € 144 |
| Societal | Only F-ACT participants | Trial costs | 48906 | 10692 | € 67 | € 15 | –€ 93 | € 125 |
| Healthcare | maximum implementation | Trial costs | 74100 | 16200 | € 51 | € 11 | –€ 128 | € 157 |
| Healthcare | conservative trial based | Trial costs | 9386 | 2052 | € 6 | € 1 | –€ 16 | € 20 |
| Healthcare | Optimistic trial based | Trial costs | 56316 | 12312 | € 39 | € 8 | –€ 98 | € 119 |
| Healthcare | Only F-ACT participants | Trial costs | 48906 | 10692 | € 34 | € 7 | –€ 85 | € 103 |